HIV epidemic has become the major problems among people with injecting drugs (PWIDs) in Nepal. The study was carried out to assess the prevalence of sexually transmitted diseases including HIV/AIDS among PWIDs.
INTRODUCTION
In Nepal, the spread of Human Immunodeficiency Virus (HIV) is concentrated among Key Affected Populations (KAPs) comprising of people who inject drugs (PWIDs), men who have sex with men (MSM), labor migrants, spouses, and Female Sex Workers (FSWs). 1, 2 The transmission of HIV is largely determined by KAPs and consequential health risk behaviors. 1, 3 In Nepal, the National Center for AIDS and STD Control (NCASC) aims to track patterns of HIV incidence and prevalence, stir elated awareness, and risk behaviors among high-risk populations. The estimated global prevalence of HCV was 60-80% of IDUs, HBV prevalence of 5-10%. 4 HIV infection shows a steady decreasing trend, but the number of cases remains high in Nepal. 5 Integrated Biological and Behavioral Surveillance (IBBS) surveys have been successfully conducted in various rounds in Nepal for the last decade among key populations at NCASC with support from USAID, Global Fund and Pooled Fund. Evidences from different rounds of IBBS surveys carried out in Nepal suggest that HIV prevalence is still high among PWID compared to other Key population such as Female Sex workers (FSW) and Male having sex with Male (MSM). 6 This is six round of IBBS surveys among PWID in west to far west Terai Highway Districts.
IBBS surveys are meant to generate evidence on the prevalence and risk behaviors for HIV amongst highrisk-groups across Nepal. The goal of IBBS is to guide HIV prevention planning and resource allocation and to inform the development of effective HIV prevention interventions for key populations. 7 The survey was conducted to monitor trends in HIV and STI prevalence and to explore behavioral information from high-risk groups. The objective of the survey is to determine the prevalence of HIV, syphilis, Hepatitis B and Hepatitis C among PWIDs in Western to Farwestern Terai Highway districts, Nepal.
METHODS
Integrated Biological and Behavioral Surveillance (IBBS) survey was descriptive cross-sectional in design, conducted during the March-April 2017 among male PWIDS with more than 16 years of age who had been injecting drugs for at least three months prior to the date of the survey. This survey was conducted in Western to Far West Terai Districts namely Rupandehi, Kapilvastu, Dang, Banke, Bardiya, Kailali and Kanchanpur of Nepal. Two stage cluster sampling method was used to select the PWIDs. All together 132 clusters were selected from Survey highway districts, 30 clusters were selected from the sampling to ensure proper representation of the survey population. The same size of sample used for previous rounds of IBBS surveys was used to select 300 PWIDs.
Biological data were collected applying principles of handling biological data for external quality assurance. A standardized format of the questionnaire is used for each group, which is repeated with relevant modification in the following rounds of the survey to explore behavioral changes over time. 6 The survey used a structured questionnaire to assess background characteristics and injecting behaviors. The questionnaire was developed with reference to the existing questionnaire used in the previous round. All data collection tools were developed in Nepali and the interviews were conducted in Nepali language by female enumerators. The field team was provided with 6 days of training. The training including mock interview exercises was facilitated by the relevant experts.
Before the interview, PWIDs were informally asked a few questions in order to ensure that they met the eligibility criteria set for the study. Injecting marks were also observed in order to screen for injecting behavior (i.e. skin lesions, abscess, or punctured wounds). PWIDs were checked for any clinical symptoms of STIs by a certified health assistant who also filled out a checklist of health information provided by each participant. The progress of the fieldwork was monitored throughout the survey period. The electronic data was extracted into MS Excel for verification and transferred into Statistical Package for the Social Sciences (SPSS) version 21 and descriptive analysis was done. Approval for the study was obtained from the Nepal Health Research Council. Confidentiality was maintained throughout the study. Interviewers had taken interviews in a private room after verbal informed consent was obtained.
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RESULTS
The study revealed that among 300 PWID, 71 (23.7%) were found to be HCV reactive, 16 (5.3%) were HIV positive, and 8 (2.7%) of the respondents were found to be HBsAg reactive in Western and Far western Terai districts of Nepal (Table 1) . (Table 5 ). 
DISCUSSION
The study revealed an HIV prevalence of 5.3% among the PWIDs in the study area of Nepal. Moreover, nearly a quarter of the respondents (23.7%) were found to be reactive to HCV. Another 2.7% of the respondents were found to be HBsAg reactive. Likewise, the prevalence of active syphilis among the sampled population was calculated as two percent, with a further 1.3% having previous history of syphilis. Furthermore, co-infection of HIV and HCV as well as HCV and HBsAg was detected in 3.7% and 0.7% of the respondents respectively. In 2017, it was increased to 5.3%, likewise, the prevalence of active syphilis has increased from previous round of IBBS survey (0.3% in 2015 to 2.0% in 2017) where the HIV prevalence among PWIDs in the Kathmandu Valley in 2015 was found to be 6.4%, HCV prevalence was 22.0%. 1 HCV prevalence among PWID had increased significantly from 8.0% in 2015 to 23.7% in 2017 and HBV prevalence also increases to 2.7% in 2017 from 1.7% in 2015. Injecting drug use accounts for approximately 10% of HIV infections globally and the estimated global prevalence of hepatitis C in people who inject drugs is 67%. 8 In another study, the prevalence of HIV among FIDUs in 2017 was 1.9% syphilis was 3.9%, Hepatitis B and Hepatitis C were 2.6% and 1.3% respectively. About two out of three female injecting drug users were identified with HIV during the survey and remaining were previously diagnosed. 7 It was found that 96.0% of the PWIDs have had sexual intercourse in their lifetime. More than threefourths of the PWIDs disclosed having their first sexual intercourse by the age of 20 years. The study also found that majority of respondents had sexual intercourse over the past 12 months. However, the number of female sexual partners over the course of 12 months revealed great differences with the number ranging from one partner to seven or more. More than half of the PWIDs (58.1%) were found to have had sexual intercourse with a single partner, followed by PWIDs who had 2-3 partners (33.2%). Various study reported that the majority had sex with males, which was predominantly anal, had an average number of 74 sex partners (last three months), 92.0% had used lubricant during their last sex act, 38.0% perceived themselves as at risk of HIV and the majority knew of a place for confidential HIV testing place. Findings from studies suggest that several reasons account for lack of condom use among high-risk MSM. 9, 10 In the previous study, just over 3 in 10 had been injecting drugs for over 5 years while one third had been found to be injecting for past 2-5 years and 8.7 percent of the respondents had started injecting drugs within a year. Regarding the frequency of injections, in the week prior to the interview, 16 percent of the respondents reported that they had injected on an average of 4-6 times a week, while 27.2 percent were found to have injected at least 2-3 times a week. Further, 10.7 percent claimed to be injected daily. Likewise, the majority of the respondents (73.6%) reported injecting only once a day, while asked about the frequency of drug injection in the last day. In addition, 4.1 percent said that they injected three or more times on the day before interview. 1 In other study, authors found that more than three fourth of the respondents were injecting drug users nearly half of them had shared needles or syringes in the past month, most of them were involved in commercial or casual sex respectively. 11 In this survey, the mean duration (in months) of injecting drugs by PWIDs was calculated to be 69.23 + 69.17 months with greater than 60 months (36.3%), 25-60 months (27.7%) and 12-24 months (25.7%) being the most prevalent time durations. Similarly, the mean age at first injection of drugs was calculated to be 24.60 + 6.58 years; the highly represented age-groups being 16-24 years and greater than 24 years at 55.0% and 41.7% respectively. This finding outlines the age groups and user-groups that need to be specifically targeted to reduce the burden of HIV/ AIDS and STI due to PWIDs. In the previous study, the prevalence of HIV infection was highest for the following factors aged ≥30 years (32%), illiterate (28.5%), and injecting drugs >10 years (35%). 5 The risk of HIV/AIDS and STI varies according to the drug injecting practice being adopted by the PWIDs. In this survey, majority (92.0%) of the PWIDs responded positively regarding injecting drug in the past one month. Previous study confirmed that the transmission of STI varies with HIV epidemic phase. 12 In this study, majority (95.1%) of the PWIDs highlighted sharing needle with their friend in the last one week. There is evidence that reduction of the sharing of needles/ syringes had tremendous contribution in the harm reduction in HIV transmission. The sharing of a cooker/vial/container, cotton/filter or rise water was also found to be absent from majority (92.0%) of the PWIDs. 13 Consequently, the harm reduction strategies have to be applied to reduce the HIV/AIDS and STIs transmission.
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LIMITATIONS
As this survey was conducted in PWIDs of 7 Districts of Nepal, this may not be generalized in context of general population of Nepal. As we provided the minimum cost of transportation to the PWIDs, there may be some possibilities that same PWIDSs can participate in multiple rounds of survey because a survey conducted in the same area among the same group over the time.
IMPLICATION
The findings of survey are valuable for monitoring HIV prevention, care and treatment programs and estimating and projecting HIV infections. The information can be used by donors, policymakers, program designers, implementers, academicians and civil society organizations in order to track the level of HIV epidemic among PWIDs and their related risk behaviors.
CONCLUSSION
There is high prevalence of HIV, HCV, HBV and active syphilis among the PWIDs. Co-infection of HIV and HCV as well as HCV and Hepatitis B were also prevalent. Peer and outreach education, partnerships with HTC/STI clinics, and inclusion of care and support are necessary for increasing exposure of the PWIDs to the programs and services related to HIV and AIDS. Comprehensive education and awareness program is required to reduce the prevalence.
